Veterinary Pharmacy In Ukraine

Press Release (ePRNews.com) - KYIV, Ukraine - Oct 10, 2016 - America 2030, LLC is announcing it has reached an agreement with a group of investors as regards the investments into Ukrainian veterinary pharmacy.

At present, no proper attention is given to the formation and development of veterinary pharmacy in Ukraine. The functioning of this industry and of the market of veterinary medicines is an important prerequisite for stable social, economic and political development of any nation.

Pharmaceutical production for the needs of veterinary medicine is a strong factor in formation of supply of animal-based food as long as healthy livestock is the main requirement for economic efficiency of animal husbandry. Ukraine’s integration with the EU requires transfer of veterinary pharmacy into European and global levels and quality standards.

The President of America 2030, LLC, Vladimir Sklaroff says: “To stabilize and develop animal farming as one of the most competitive sectors, the companies and corporations which combine development, production and sales of veterinary medicines are the most prospective in the market economy.”

America 2030 believes that cooperation with known international companies is another acceptable option. That will help to raise the interest of manufacturers in producing more efficient new medicines.

America 2030, LLC has been providing a wide range of business services to its clients since 1984. These services are directed towards export and import activities, search for investments, business brokerage, bankruptcy, purchase and sale of businesses and consulting.

www.america2030.net

Source : America2030
Business Info :
America 2030, LLC

You may also like this  

CATEGORIES : Medical
DISCLAIMER : If you have any concerns regarding this press release, please contact the Author / Media Contact / Business of this press release. ePRNews is not resposible for the accuracy of the news posted and do not endorse, support any product/services/business mentioned and hereby disclaims any content contained in this press release.

Login

Or using ePRNews Account

Don't have an account ? Sign Up

Register New Account

Or form here

Already have an account ? Login

Reset Password

Already have an account ? Login